← FDA Drug Approvals (Drugs@FDA)

LACOSAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2022-03-17

Drug application

FDA Application #

ANDA204787

Application type

Abbreviated New Drug Application (Generic)

Brand name

LACOSAMIDE

Generic name

LACOSAMIDE

Active ingredients

LACOSAMIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2022-03-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown